Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.31 Billion CNY | -3.21% |
| 2022 | 2.38 Billion CNY | 3.72% |
| 2021 | 2.3 Billion CNY | 26.61% |
| 2020 | 1.81 Billion CNY | -5.63% |
| 2019 | 1.92 Billion CNY | 4.03% |
| 2018 | 1.85 Billion CNY | 6.75% |
| 2017 | 1.73 Billion CNY | 8.63% |
| 2016 | 1.59 Billion CNY | 0.31% |
| 2015 | 1.59 Billion CNY | 23.13% |
| 2014 | 1.29 Billion CNY | 39.23% |
| 2013 | 929.18 Million CNY | 503.37% |
| 2012 | 153.99 Million CNY | 3.88% |
| 2011 | 148.25 Million CNY | 40.07% |
| 2010 | 105.84 Million CNY | 37.5% |
| 2009 | 76.97 Million CNY | 10.56% |
| 2008 | 69.62 Million CNY | 5.55% |
| 2007 | 65.95 Million CNY | 5.77% |
| 2006 | 62.36 Million CNY | -10.7% |
| 2005 | 69.83 Million CNY | -8.29% |
| 2004 | 76.15 Million CNY | 214.09% |
| 2003 | 24.24 Million CNY | 91.59% |
| 2002 | 12.65 Million CNY | -65.58% |
| 2001 | 36.76 Million CNY | -34.12% |
| 2000 | 55.8 Million CNY | -46.74% |
| 1999 | 104.78 Million CNY | -9.25% |
| 1998 | 115.46 Million CNY | -56.72% |
| 1997 | 266.78 Million CNY | 17.78% |
| 1996 | 226.51 Million CNY | 6.83% |
| 1995 | 212.04 Million CNY | -0.85% |
| 1994 | 213.86 Million CNY | 19.71% |
| 1993 | 178.64 Million CNY | 88.44% |
| 1992 | 94.8 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 535.83 Million CNY | -5.08% |
| 2024 Q3 | 445.72 Million CNY | -15.48% |
| 2024 Q1 | 564.53 Million CNY | -9.54% |
| 2023 Q3 | 504.86 Million CNY | -18.95% |
| 2023 Q1 | 582.79 Million CNY | -13.76% |
| 2023 Q2 | 622.87 Million CNY | 6.88% |
| 2023 FY | 2.31 Billion CNY | -3.21% |
| 2023 Q4 | 624.06 Million CNY | 23.61% |
| 2022 Q4 | 675.79 Million CNY | 32.36% |
| 2022 Q2 | 614 Million CNY | 4.38% |
| 2022 Q3 | 510.57 Million CNY | -16.85% |
| 2022 FY | 2.38 Billion CNY | 3.72% |
| 2022 Q1 | 588.24 Million CNY | -1.95% |
| 2021 Q2 | 602.89 Million CNY | 9.06% |
| 2021 Q1 | 552.79 Million CNY | 12.91% |
| 2021 FY | 2.3 Billion CNY | 26.61% |
| 2021 Q3 | 547.39 Million CNY | -9.2% |
| 2021 Q4 | 599.94 Million CNY | 9.6% |
| 2020 Q1 | 342.99 Million CNY | -32.32% |
| 2020 Q2 | 496.33 Million CNY | 44.71% |
| 2020 Q3 | 490.07 Million CNY | -1.26% |
| 2020 Q4 | 489.6 Million CNY | -0.1% |
| 2020 FY | 1.81 Billion CNY | -5.63% |
| 2019 FY | 1.92 Billion CNY | 4.03% |
| 2019 Q4 | 506.81 Million CNY | -0.58% |
| 2019 Q3 | 509.76 Million CNY | 5.19% |
| 2019 Q2 | 484.62 Million CNY | 13.66% |
| 2019 Q1 | 426.38 Million CNY | -23.71% |
| 2018 Q3 | 437 Million CNY | -14.62% |
| 2018 Q4 | 558.87 Million CNY | 27.89% |
| 2018 FY | 1.85 Billion CNY | 6.75% |
| 2018 Q1 | 345.2 Million CNY | -41.36% |
| 2018 Q2 | 511.82 Million CNY | 48.27% |
| 2017 Q2 | 389.2 Million CNY | 25.87% |
| 2017 Q3 | 448.62 Million CNY | 15.27% |
| 2017 Q4 | 588.68 Million CNY | 31.22% |
| 2017 FY | 1.73 Billion CNY | 8.63% |
| 2017 Q1 | 309.2 Million CNY | -49.7% |
| 2016 Q3 | 337.29 Million CNY | -14.79% |
| 2016 Q2 | 395.82 Million CNY | 58.33% |
| 2016 FY | 1.59 Billion CNY | 0.31% |
| 2016 Q4 | 614.75 Million CNY | 82.26% |
| 2016 Q1 | 250 Million CNY | -58.91% |
| 2015 Q2 | 344.34 Million CNY | 18.75% |
| 2015 Q1 | 289.97 Million CNY | -30.13% |
| 2015 FY | 1.59 Billion CNY | 23.13% |
| 2015 Q4 | 608.38 Million CNY | 73.72% |
| 2015 Q3 | 350.21 Million CNY | 1.7% |
| 2014 Q4 | 415.03 Million CNY | 25.07% |
| 2014 FY | 1.29 Billion CNY | 39.23% |
| 2014 Q2 | 294.04 Million CNY | 16.31% |
| 2014 Q1 | 252.8 Million CNY | -37.92% |
| 2014 Q3 | 331.82 Million CNY | 12.85% |
| 2013 Q3 | 270.44 Million CNY | 19.5% |
| 2013 FY | 929.18 Million CNY | 503.37% |
| 2013 Q4 | 407.25 Million CNY | 50.59% |
| 2013 Q1 | 25.16 Million CNY | -55.7% |
| 2013 Q2 | 226.31 Million CNY | 799.38% |
| 2012 Q2 | 45.9 Million CNY | 105.16% |
| 2012 Q3 | 28.91 Million CNY | -37.02% |
| 2012 Q4 | 56.8 Million CNY | 96.45% |
| 2012 FY | 153.99 Million CNY | 3.88% |
| 2012 Q1 | 22.37 Million CNY | -47.1% |
| 2011 FY | 148.25 Million CNY | 40.07% |
| 2011 Q4 | 42.29 Million CNY | 34.41% |
| 2011 Q3 | 31.46 Million CNY | -35.34% |
| 2011 Q2 | 48.66 Million CNY | 88.49% |
| 2011 Q1 | 25.81 Million CNY | 38.49% |
| 2010 Q3 | 32 Million CNY | -21.64% |
| 2010 Q1 | 14.35 Million CNY | -41.44% |
| 2010 Q2 | 40.84 Million CNY | 184.59% |
| 2010 FY | 105.84 Million CNY | 37.5% |
| 2010 Q4 | 18.64 Million CNY | -41.75% |
| 2009 Q2 | 28.33 Million CNY | 362.07% |
| 2009 FY | 76.97 Million CNY | 10.56% |
| 2009 Q4 | 24.5 Million CNY | 36.12% |
| 2009 Q3 | 18 Million CNY | -36.45% |
| 2009 Q1 | 6.13 Million CNY | -37.44% |
| 2008 Q3 | 31.52 Million CNY | 70.31% |
| 2008 FY | 69.62 Million CNY | 5.55% |
| 2008 Q1 | 9.79 Million CNY | 72.88% |
| 2008 Q2 | 18.5 Million CNY | 89.03% |
| 2008 Q4 | 9.8 Million CNY | -68.91% |
| 2007 Q1 | 8.52 Million CNY | -22.21% |
| 2007 Q4 | 5.66 Million CNY | -73.78% |
| 2007 Q3 | 21.59 Million CNY | -28.43% |
| 2007 Q2 | 30.17 Million CNY | 254.12% |
| 2007 FY | 65.95 Million CNY | 5.77% |
| 2006 Q2 | 21.67 Million CNY | 166.13% |
| 2006 Q3 | 21.58 Million CNY | -0.43% |
| 2006 Q4 | 10.95 Million CNY | -49.24% |
| 2006 FY | 62.36 Million CNY | -10.7% |
| 2006 Q1 | 8.14 Million CNY | -14.17% |
| 2005 Q4 | 9.49 Million CNY | -49.38% |
| 2005 Q1 | 15.02 Million CNY | -25.34% |
| 2005 Q2 | 26.57 Million CNY | 76.9% |
| 2005 Q3 | 18.74 Million CNY | -29.45% |
| 2005 FY | 69.83 Million CNY | -8.29% |
| 2004 FY | 76.15 Million CNY | 214.09% |
| 2004 Q1 | 7.85 Million CNY | 15.43% |
| 2004 Q2 | 33.42 Million CNY | 325.52% |
| 2004 Q3 | 14.75 Million CNY | -55.87% |
| 2004 Q4 | 20.11 Million CNY | 36.4% |
| 2003 Q2 | 4.3 Million CNY | 53.29% |
| 2003 Q4 | 6.8 Million CNY | -34.1% |
| 2003 Q1 | 2.8 Million CNY | -26.54% |
| 2003 Q3 | 10.32 Million CNY | 139.85% |
| 2003 FY | 24.24 Million CNY | 91.59% |
| 2002 Q3 | 3.13 Million CNY | 12.89% |
| 2002 FY | 12.65 Million CNY | -65.58% |
| 2002 Q1 | 2.91 Million CNY | 0.0% |
| 2002 Q2 | 2.77 Million CNY | -4.87% |
| 2002 Q4 | 3.82 Million CNY | 21.95% |
| 2001 FY | 36.76 Million CNY | -34.12% |
| 2000 FY | 55.8 Million CNY | -46.74% |
| 1999 FY | 104.78 Million CNY | -9.25% |
| 1998 FY | 115.46 Million CNY | -56.72% |
| 1997 FY | 266.78 Million CNY | 17.78% |
| 1996 FY | 226.51 Million CNY | 6.83% |
| 1995 FY | 212.04 Million CNY | -0.85% |
| 1994 FY | 213.86 Million CNY | 19.71% |
| 1993 FY | 178.64 Million CNY | 88.44% |
| 1992 FY | 94.8 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 22.81 Billion CNY | 89.869% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 10.05 Billion CNY | 77.016% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | 65.663% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | -605.036% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 121.77 Million CNY | -1798.424% |
| NanJing Pharmaceutical Company Limited | 53.58 Billion CNY | 95.686% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.28 Billion CNY | -80.05% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 3.07 Billion CNY | 24.827% |